Limited time offer! 10% off your first blood test order!
17-marker comprehensive organ screen covering blood count, liver, kidney, and calcium markers in a single home collection.
or 4 interest-free payments of £14.75 with Klarna
A 17-marker comprehensive organ function screen combining full blood count, liver function, kidney function, and bone markers.
The Complete Organ Function Screen combines the most clinically useful markers across four organ systems into a single, comprehensive assessment.
Full blood count (6 parameters): haemoglobin, RBC count, WBC count, platelet count, MCV, and haematocrit — screening for anaemia, infection, and haematological conditions.
Liver function (6 markers): ALT, AST, GGT, alkaline phosphatase, bilirubin, and albumin — a comprehensive picture of hepatocyte health, biliary function, and synthetic capacity.
Kidney function (4 markers): creatinine, eGFR, urea, and uric acid — assessing renal filtration, nitrogen clearance, and metabolic risk.
Bone and calcium metabolism (2 markers): corrected calcium and alkaline phosphatase (ALP contributes to both liver and bone assessment) — screening for calcium abnormalities and bone disease.
This panel is suitable as a comprehensive annual baseline or for people who want to assess multiple organ systems simultaneously without running multiple separate tests. Home fingerstick kit available. GMC-physician reviewed results within 3 to 5 working days.
Understand what each marker measures, why it matters, and what the science says — not just a list of numbers.
Core haematological screen for anaemia, immune status, clotting capacity, and red cell morphology.
Comprehensive liver assessment covering hepatocyte damage, biliary function, and synthetic capacity.
Renal filtration, nitrogen clearance, and metabolic risk assessment.
Albumin-adjusted total calcium; screens for hypo- and hypercalcaemia and their metabolic causes.
This panel is designed for adults who want a comprehensive, evidence-based picture of their metabolic health — not a GP referral panel.
Adults wanting a comprehensive annual organ function baseline
Those on medications requiring multi-organ monitoring (statins, methotrexate, NSAIDs)
People with fatigue or non-specific symptoms wanting a broad screen
Those with a family history of liver, kidney, or bone disease wanting routine monitoring
This panel provides a broad screen across four organ systems but is not exhaustive in any one domain. Liver assessment does not include viral hepatitis serology or clotting studies. Kidney assessment does not include urinary protein (ACR or PCR), electrolytes, or phosphate. Full blood count does not include a WBC differential or reticulocyte count. Bone assessment uses corrected calcium only — PTH, vitamin D, and bone resorption markers are not included. Mildly abnormal values in the context of acute illness may not reflect underlying chronic organ disease; retesting after recovery is advisable. Please discuss significantly abnormal results with your GP promptly.
From order to physician-reviewed report in as little as three working days.
Three options designed to fit your schedule, location, and preference — all producing a laboratory-standard sample.
Adults 18+ in mainland UK. Not suitable if you have had a transfusion in the last 3 months.
Order anytime; kit dispatched within 24 hours Mon–Fri.
Allow 24–48 hours for sample transit on top of lab processing time.
Adults 18+ within 20 miles of a serviced city centre.
Mon–Sun, 06:00–20:00. Next-day booking typical.
Sample reaches the lab within 24 hours of collection.
Adults 16+ with photo ID. Paediatric draws by appointment at selected sites.
Mon–Fri, with Saturday hours at most metropolitan locations.
Samples processed same-day at the receiving clinic.
Every test is processed in a UKAS ISO 15189-accredited laboratory, overseen by GMC-registered physicians, and governed by UK GDPR. No overseas processing, no offshore data.
Follow these guidelines to ensure accurate, reproducible results. Most markers are sensitive to recent food, exercise, and sleep.
Can't find your answer? Our clinical support team is available Monday to Friday, 9am–5pm.
Contact supportA standard NHS blood check at a GP practice often includes a core set of markers determined by the clinical indication. This comprehensive organ function screen systematically covers six liver markers (including GGT, which is often omitted), four kidney markers (including uric acid, which is rarely requested unless gout is suspected), and corrected calcium alongside the standard FBC. The combination of all these in a single proactive assessment — rather than waiting for symptoms to prompt individual tests — is the key difference. The physician narrative accompanying your results also provides interpretation across all markers together, rather than just flagging individual abnormal values.
Yes, particularly for medications that affect the liver or kidneys. Statins (liver monitoring — ALT, AST), NSAIDs (kidney monitoring — creatinine, eGFR), methotrexate (liver — full LFT), ACE inhibitors (kidney — creatinine, eGFR, potassium though electrolytes not included here), and chemotherapy agents (full blood count, liver, kidney) are all monitored using markers in this panel. If you are on long-term medications requiring routine monitoring and want to supplement NHS monitoring with private testing, this panel provides a comprehensive multi-system check in a single home collection.
Total calcium in the blood is partly bound to albumin (a blood protein). When albumin is low (e.g. in malnutrition, liver disease, or inflammation), total calcium appears artificially low even if free (ionised) calcium is normal. Corrected calcium adjusts total calcium for the albumin level, giving a more accurate picture of the biologically active calcium. This correction is important because clinical decisions about hypocalcaemia and hypercalcaemia should be based on true calcium availability. Corrected calcium is the standard reported in most clinical settings. If there is clinical concern about accuracy (e.g. in critical illness), ionised calcium should be measured directly.
Annual testing is appropriate for most adults over 35 as a proactive organ health baseline. For those on long-term medications requiring monitoring, frequency is guided by prescribing guidelines — typically every 3 to 12 months depending on the drug and organ system affected. For those with identified abnormalities (e.g. mildly elevated ALT or borderline eGFR), the physician report will recommend a specific retesting interval. For healthy younger adults with no risk factors, testing every 2 to 3 years as part of a broader health MOT may be more appropriate.
